Short-Term Success Rates of Smoking Cessation Support Programs and Factors Predicting Smoking Relapse: Using Data from a Smoking Cessation Clinic in a Hospital
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Although the number of medical institutions running a smoking cessation clinic is on the rise, there remains a paucity of research on the long- and short-term success rates of smoking cessation programs, as well as on smoking relapse rates, before and after project implementation. This study assessed the general characteristics of patients visiting the smoking cessation clinic, success rate of smoking cessation in the short term, and risks of relapse. Methods: Medical records from March 2015 to April 2017 were analyzed and telephone surveys were conducted with 151 smokers who visited a hospital smoking cessation clinic from March 2015 to April 2017. Results: Of the 139 smokers who were eligible for follow-up, 22 (15.8%) failed to quit smoking initially. The clinic’s 6-month success rate of smoking cessation was 64.83%. Those with higher medication compliance had a lower risk of primary failure (odds ratio, 0.056; 95% confidence interval, 0.005–0.609), whereas those with higher age (hazard ratio [HR], 0.128; P=0.0252) and a greater number of visits to the clinic (HR, 0.274; P=0.0124) had a lower risk of relapsing. Conclusion: The risk of primary failure to quit was higher with low medication compliance, and that of relapsing was higher with lower age and fewer number of clinic visits. Various evaluation and analysis methods can be carried out in the future based on the accumulated data for maintenance of smoking cessation and relapse prevention.
Abstract
Background: Although the number of medical institutions running a smoking cessation clinic is on the rise, there remains a paucity of research on the long- and short-term success rates of smoking cessation programs, as well as on smoking relapse rates, before and after project implementation. This study assessed the general characteristics of patients visiting the smoking cessation clinic, success rate of smoking cessation in the short term, and risks of relapse. Methods: Medical records from March 2015 to April 2017 were analyzed and telephone surveys were conducted with 151 smokers who visited a hospital smoking cessation clinic from March 2015 to April 2017. Results: Of the 139 smokers who were eligible for follow-up, 22 (15.8%) failed to quit smoking initially. The clinic’s 6-month success rate of smoking cessation was 64.83%. Those with higher medication compliance had a lower risk of primary failure (odds ratio, 0.056; 95% confidence interval, 0.005–0.609), whereas those with higher age (hazard ratio [HR], 0.128; P=0.0252) and a greater number of visits to the clinic (HR, 0.274; P=0.0124) had a lower risk of relapsing. Conclusion: The risk of primary failure to quit was higher with low medication compliance, and that of relapsing was higher with lower age and fewer number of clinic visits. Various evaluation and analysis methods can be carried out in the future based on the accumulated data for maintenance of smoking cessation and relapse prevention.
참고문헌 (16)
- Burns DM, "Harrison’s principles of internal medicine", pp.2729~2732 (2005), McGraw-Hill
- "Assessing socio-economic effects of major health risk factors and the effects of regulatory policy" (2015)[URL]
- "The Sixth Korea National Health and Nutrition Examination Survey (KNHANES VI-2)" (2014)[URL]
- "Smoking rate (OECD)" (2019)[URL]
- 백유진, "국민건강보험공단 금연치료지원사업", 대한의사협회지, 61(3), pp.157~162 (2018), 대한의사협회[DOI]
- Velicer WF, "A comparison of four self-report smoking cessation outcome measures", Addict Behav, 29, pp.51~60 (2004)
- Celik I, "Nationwide Smoking Cessation Treatment Support Program : Turkey project", Health Policy, 119, pp.50~56 (2015)
- Land T, "Medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in smoking prevalence", PLoS One, 5, pp.e9770~ (2010)
- Kumiko S, "Smoking prevalence and beliefs on smoking cessation among members of the Japanese Cancer Association in 2006 and 2010", Cancer Sci, 103, pp.1595~1599 (2012)
- Tait RJ, "Effectiveness of a smoking cessation intervention in older adults", Addiction, 102, pp.148~155 (2007)
- Jorenby DE, "Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation : a randomized controlled trial", JAMA, 296, pp.56~63 (2006)
- Nakamura M, "Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers", Clin Ther, 29, pp.1040~1056 (2007)
- Lee JH, "A longer course of varenicline therapy improves smoking cessation rates", Prev Cardiol, 11, pp.210~214 (2008)
- Garrison GD, "Varenicline : a first-line treatment option for smoking cessation", Clin Ther, 31, pp.463~491 (2009)
- Lindson-Hawley N, "Motivational interviewing for smoking cessation", Cochrane Database Syst Rev, (3), pp.CD006936~ (2015)
- 박수잔, "호기 중 일산화탄소와 소변 코티닌 검사의 흡연상태 타당도 분석", 예방의학회지, 40(4), pp.297~304 (2007), 대한예방의학회